POP4 Human

Processing Of Precursor 4 Human Recombinant
Shipped with Ice Packs
In Stock

Description

POP4 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 243 amino acids (1-220 a.a.) and having a molecular mass of 27.8kDa.
POP4 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
POP4, also known as Processing of Precursor 4, belongs to the eukaryotic/archaeal RNase P protein component 1 family. This protein serves as a subunit in two crucial small nucleolar ribonucleoprotein complexes: the endoribonuclease for mitochondrial RNA processing complex and the ribonuclease P complex. Primarily located in the nucleus, POP4 rapidly interacts with the RNA component of these complexes, playing a vital role in the processing of precursor RNAs.
Description
Recombinant Human POP4, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein consists of 243 amino acids, with 220 amino acids (1-220 a.a.) representing the POP4 sequence and an additional 23 amino acid His-tag at the N-terminus. With a molecular weight of 27.8 kDa, this recombinant protein is purified using proprietary chromatographic techniques.
Physical Appearance
The product is a clear solution that has been sterilized through filtration.
Formulation
The POP4 protein solution is provided at a concentration of 1 mg/ml. It is formulated in a buffer containing 20mM Tris-HCl (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the protein solution should be kept at 4°C. For extended storage, it is recommended to store the solution at -20°C. The addition of a carrier protein like HSA or BSA (0.1%) is advisable for long-term storage. Repeated freezing and thawing of the protein solution should be avoided.
Purity
The purity of the POP4 protein is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
RPP29, Ribonuclease P protein subunit p29, hPOP4.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMKSVIYH ALSQKEANDS DVQPSGAQRA EAFVRAFLKR STPRMSPQAR EDQLQRKAVV LEYFTRHKRK EKKKKAKGLS ARQRRELRLF DIKPEQQRYS LFLPLHELWK QYIRDLCSGL KPDTQPQMIQ AKLLKADLHG AIISVTKSKC PSYVGITGIL LQETKHIFKI ITKEDRLKVI PKLNCVFTVE TDGFISYIYG SKFQLRSSER SAKKFKAKGT IDL.

Q&A

What is the biological function of the human POP4 protein?

The human POP4 protein is a subunit of two essential ribonucleoprotein complexes: RNase P and RNase MRP. RNase P is primarily involved in the maturation of pre-tRNA molecules by cleaving their 5' leader sequences . RNase MRP participates in pre-rRNA processing, contributing to the formation of ribosomal RNA . Both complexes share structural similarities and several protein subunits, including POP4 . The protein localizes to the nucleolus, where it associates with RNA components of these complexes . Immunoprecipitation studies have demonstrated that POP4 directly interacts with RNA molecules and contributes to enzymatic activities such as cleavage reactions necessary for RNA maturation .

How is POP4 localized within human cells?

POP4 is localized predominantly in the nucleus, with a specific accumulation in the nucleolus . Transfection experiments using epitope-tagged versions of POP4 have confirmed its nucleolar localization . This localization aligns with its role in RNA processing since both RNase P and RNase MRP function within the nucleolus. The nucleolar environment provides a hub for ribonucleoprotein assembly and RNA metabolism, making it an ideal site for POP4's activities .

What experimental methods can be used to study POP4's interactions with RNA?

To study POP4's interactions with RNA components of RNase P and RNase MRP complexes, researchers commonly use immunoprecipitation assays coupled with RNA analysis techniques . For example:

  • Immunoprecipitation: Polyclonal antibodies raised against recombinant POP4 can be used to pull down RNA-protein complexes from cell extracts .

  • RT-PCR: Reverse transcription PCR can identify specific RNA molecules associated with immunoprecipitated POP4 complexes.

  • RNA sequencing: High-throughput sequencing can provide insights into the diversity of RNA species interacting with POP4.

  • Crosslinking assays: These assays help stabilize transient interactions between POP4 and its RNA partners for detailed structural studies.

These methods enable researchers to delineate the molecular mechanisms underlying POP4's role in RNA metabolism.

What are the structural features of human POP4?

Human POP4 is a highly basic protein consisting of 220 amino acids . It contains regions that facilitate interactions with RNA molecules and other protein subunits within RNase P and RNase MRP complexes . The amino acid sequence reveals conserved motifs critical for its enzymatic functions and structural integrity . Recombinant forms of POP4 tagged with His-tags have been expressed in E. coli for structural studies, revealing a predicted molecular mass of approximately 27.8 kDa . Post-translational modifications may slightly alter this molecular weight during cellular processes .

How can researchers validate antibodies targeting human POP4?

Antibodies targeting human POP4 can be validated using multiple approaches:

  • Western blotting: Detects the presence of POP4 protein in cell lysates based on its molecular weight (~30 kDa) .

  • Immunofluorescence: Confirms the localization of POP4 within cells, particularly its nucleolar accumulation .

  • ELISA: Quantifies antibody binding affinity to recombinant or native forms of POP4.

  • Functional assays: Assess whether antibody binding affects RNase P enzymatic activity or disrupts RNA-protein interactions.

Prestige Antibodies®, such as those provided by Sigma Aldrich, are extensively validated using immunohistochemistry and immunofluorescence against various tissues .

What are the implications of alternative splicing on POP4 function?

Alternative splicing generates multiple transcript variants of the human POP4 gene . These variants may encode proteins with distinct functional properties or localization patterns. While some isoforms retain their ability to integrate into RNase P/MRP complexes, others might exhibit altered enzymatic activities or fail to localize correctly within the nucleolus. Studying these variants provides insights into regulatory mechanisms controlling RNA processing under different physiological conditions.

How does POP4 contribute to enzymatic activity within RNase P/MRP complexes?

POP4 plays an integral role in stabilizing the structure of RNase P/MRP complexes and facilitating their enzymatic functions . Within RNase P, it aids in cleaving pre-tRNA molecules at specific sites to generate mature tRNAs essential for translation . In RNase MRP, it contributes to cleavage reactions involved in pre-rRNA processing, which are crucial for ribosome assembly . Experimental data show that anti-POP4 immunoprecipitates possess enzymatic activity consistent with these roles .

What are common experimental challenges when studying POP4?

Researchers often face challenges such as:

  • Low expression levels: Detecting endogenous POP4 requires sensitive techniques like immunoprecipitation or RT-PCR.

  • Complex formation: Purifying intact RNase P/MRP complexes containing functional POP4 can be difficult due to their dynamic nature.

  • Cross-reactivity: Antibodies may cross-react with other proteins sharing structural similarities with POP4.

  • Post-translational modifications: These modifications may alter antibody recognition or enzymatic activity.

Optimizing experimental conditions and validating reagents are essential steps to overcome these challenges.

Are there known diseases associated with mutations in the human POP4 gene?

While direct associations between mutations in the human POP4 gene and specific diseases remain under investigation, disruptions in RNase P/MRP functions have been linked to developmental disorders and mitochondrial dysfunctions . Given its role in fundamental RNA processing pathways, aberrations in POP4 expression or activity could contribute to broader cellular dysfunctions observed in cancer or neurodegenerative diseases.

Product Science Overview

Background of Processing of Precursor 4 (Human Recombinant)

Introduction

The processing of precursor 4 (human recombinant) involves a series of biochemical and biotechnological steps to produce a functional protein from its precursor form. This process is crucial in the field of recombinant protein production, which has significant applications in medicine, research, and biotechnology.

Recombinant Protein Production

Recombinant protein production involves the insertion of a gene encoding the desired protein into a host organism, such as bacteria, yeast, or mammalian cells. The host organism then expresses the protein, which can be harvested and purified for various applications. The precursor 4 protein is initially produced in an inactive form and requires specific processing steps to become active.

Processing Steps

  1. Gene Cloning and Expression: The gene encoding precursor 4 is cloned into an expression vector, which is then introduced into a suitable host organism. The host cells are cultured under conditions that promote the expression of the recombinant protein.

  2. Protein Extraction: Once the host cells have produced the precursor protein, it is extracted from the cells. This typically involves cell lysis, where the cells are broken open to release their contents, including the recombinant protein.

  3. Purification: The extracted protein is then purified using various chromatographic techniques. This step is crucial to remove impurities and obtain a high-purity protein product. Common methods include affinity chromatography, ion exchange chromatography, and size exclusion chromatography.

  4. Folding and Refolding: Recombinant proteins often require proper folding to achieve their functional conformation. This step may involve the use of chaperones or specific conditions that promote correct folding. In some cases, the protein may need to be refolded if it was initially produced in an incorrect conformation.

  5. Post-Translational Modifications: Some recombinant proteins require post-translational modifications, such as glycosylation or phosphorylation, to become fully functional. These modifications are typically carried out by the host cells or through additional enzymatic steps.

  6. Activation: The precursor 4 protein is initially produced in an inactive form and requires specific processing steps to become active. This may involve proteolytic cleavage, where specific enzymes cleave the precursor protein at defined sites to generate the active form.

Applications

The processed precursor 4 (human recombinant) protein has various applications in research and medicine. It can be used as a therapeutic agent, a diagnostic tool, or a research reagent. The ability to produce recombinant proteins in large quantities has revolutionized the field of biotechnology and has led to the development of numerous life-saving therapies.

Conclusion

The processing of precursor 4 (human recombinant) is a complex and multi-step process that involves gene cloning, protein expression, extraction, purification, folding, post-translational modifications, and activation. Each step is crucial to ensure the production of a high-quality and functional protein product. The advancements in recombinant protein production have opened up new possibilities in medicine and research, making it an essential area of study in biotechnology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.